Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive ...

Novartis plans to build and expand 10 U.S. facilities New facilities include six manufacturing plants and a research and development site The construction will take place over five years, create ...

SAN DIEGO — Novartis, a Swiss pharmaceutical company, announced a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure. The move ensures that ...

Amid renewed threats of import tariffs on pharmaceuticals from the Trump administration, Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and ...